ZAX.1400.P03

Developed for: psoriasis
Investigated by: Fasa University of Medical Sciences · Herbmedx Co · Zarrin Avaye Kowsar Salamat (ZAX company) and HerbmedX

today NCT06301997 · Ph 2

2023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT06301997	Feb 2023 → Jun 2025 overdue	psoriasis	Fasa University of Medical Sciences	Active not recruiting	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	ZAX.1400.P03	“ZAX.1400.P03, applied topically twice daily for 3 weeks after enrolment” NCT06301997 ↗
Route	Topical	“ZAX.1400.P03, applied topically twice daily for 3 weeks after enrolment” NCT06301997 ↗